Svetlana V. Kyosseva
Researcher
Also affiliated: Novartis (Switzerland) (1993); Bulgarian Academy of Sciences (1983–1988); University of Arkansas Medical Center (2004); University of Oklahoma Medical Center (2008); Dean McGee Eye Institute (2013); University of Oklahoma Health Sciences Center (2006–2013); University of Oklahoma (2006)
Faculty Researcher
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Svetlana V. Kyosseva's research has focused on signal transduction pathways, particularly involving mitogen-activated protein kinases. Her work has explored the roles of these pathways in various biological contexts, including studies involving animal models such as rats. Kyosseva has also investigated aspects of schizophrenia, examining underlying biological mechanisms. Her publication record includes 25 peer-reviewed articles, accumulating approximately 985 citations, and she holds an h-index of 15. She has collaborated with Donald M. Mock at the University of Arkansas for Medical Sciences on shared publications, indicating an active research network within the institution.
Metrics
- h-index: 15
- Publications: 26
- Citations: 1,006
Selected Publications
-
Antibodies against biotin‐labeled red blood cells can shorten <scp>posttransfusion</scp> survival (2022)
-
Development, validation, and potential applications of biotinylated red blood cells for posttransfusion kinetics and other physiological studies: evidenced‐based analysis and recommendations (2018)
-
In premature infants there is no decrease in 24‐hour posttransfusion allogeneic red blood cell recovery after 42 days of storage (2017)
-
Targeting MAPK Signaling in Age-Related Macular Degeneration (2016)
-
The role of the extracellular signal-regulated kinase pathway in cerebellar abnormalities in schizophrenia (2004)
-
Differential expression of mitogen-activated protein kinases and immediate early genes fos and jun in thalamus in schizophrenia (2004)
-
Mitogen-Activated Protein Kinase Signaling (2004)
-
Increased Expression of c-Jun Transcription Factor in Cerebellar Vermis of Patients with Schizophrenia (2003)
-
Differential and Region-Specific Activation of Mitogen-Activated Protein Kinases Following Chronic Administration of Phencyclidine in Rat Brain (2001)
-
Increased Levels of Transcription Factors Elk-1, Cyclic Adenosine Monophosphate Response Element-Binding Protein, and Activating Transcription Factor 2 in the Cerebellar Vermis of Schizophrenic Patients (2000)
-
Mitogen-activated protein kinases in schizophrenia (1999)
-
Synthesis of a New Photoaffinity Probe, 5‐Azido‐[<sup>32</sup>P]UDPxylose, by UDPglucuronate Carboxylyase from Wheat Germ (1995)
-
Inhibitors of Pig Kidney Trehalase (1995)
Collaboration Network
Top Collaborators
- Antibodies against biotin‐labeled red blood cells can shorten <scp>posttransfusion</scp> survival
- Antibodies against biotin‐labeled red blood cells can shorten <scp>posttransfusion</scp> survival
- Antibodies against biotin‐labeled red blood cells can shorten <scp>posttransfusion</scp> survival
- Antibodies against biotin‐labeled red blood cells can shorten <scp>posttransfusion</scp> survival
- Antibodies against biotin‐labeled red blood cells can shorten <scp>posttransfusion</scp> survival
- Antibodies against biotin‐labeled red blood cells can shorten <scp>posttransfusion</scp> survival
- Antibodies against biotin‐labeled red blood cells can shorten <scp>posttransfusion</scp> survival
- Antibodies against biotin‐labeled red blood cells can shorten <scp>posttransfusion</scp> survival
- Antibodies against biotin‐labeled red blood cells can shorten <scp>posttransfusion</scp> survival
- Antibodies against biotin‐labeled red blood cells can shorten <scp>posttransfusion</scp> survival
- Antibodies against biotin‐labeled red blood cells can shorten <scp>posttransfusion</scp> survival
Similar Researchers
Based on overlapping research topics